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West Nile Fever 
Outbreak in 
Horses and Humans, 
Spain, 2010
To the Editor: West Nile virus 
(WNV) is a member of the genus 
Flavivirus within the Japanese 
encephalitis antigenic complex. 
The enzootic virus cycle involves 
transmission between avian hosts and 
ornithophilic mosquitoes, whereas 
humans and horses are considered 
dead-end hosts. Given the recent 
increase of WNV infection in humans 
and horses in Europe, concern has 
been raised regarding public and 
animal health.
In Spain, WNV seropositivity 
has been reported for humans (2001), 
horses (2005–2008), and wild birds 
(2007–2008) (1–3). Clinical disease 
has been described for humans (2004) 
and raptors (2001–2005) (4,5) but 
not for horses. We report the main 
epidemiologic and clinical fi ndings 
of a WNV outbreak in horses and 
humans in Spain in 2010.
After the fi rst clinical case of 
West Nile fever was detected in a 
horse in September 2010 in Andalusia 
(southern Spain), a control program 
for WNV was initiated that included 
symptomatic treatment of animals, 
protection of horses in shelters 
during hours of higher vector activity, 
vaccination (not mandatory), vector 
control using pyrethroid-based 
insecticides, and elimination of 
mosquito breeding habitats. Horses 
with neurologic signs were confi rmed 
as WNV positive by detection of 
serum IgM against WNV by using 
a competitive ELISA (IDEXX IgM 
WNV Ab; IDEXX Laboratories, 
Westbrook, ME, USA). To assess 
level of WNV infection within 
affected herds, samples from sick and 
clinically healthy unvaccinated horses 
were collected 2 months after the last 
case. Serum was tested for IgG against 
WNV by using a blocking ELISA 
(Ingezim West Nile compac R.10.
WNV.K3; Ingenasa, Madrid, Spain). 
Positivity was confi rmed by a serum 
microneutralization test (SNT) against 
WNV (strain Eg101) according to 
World Organisation for Animal Health 
guidelines. Blood and cerebrospinal 
fl uid samples from clinically affected 
horses were analyzed by real-time 
reverse transcription PCR (6).
IgM against WNV was detected 
in 51 (50%) of 102 clinically ill 
horses; 15 died and 3 were euthanized. 
The most common clinical signs were 
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ataxia, disorientation, and weakness, 
followed by fever, muscular tremor, 
cranial nerves defi cit, and photophobia. 
Of the 36 infected herds, 30 were 
located in the province of Cádiz, 5 
in Seville, and 1 in Málaga (Figure). 
The fi rst WNV case was reported on 
September 10, 2010; the number of 
cases peaked at 17 in mid-September, 
then decreased until the last case 
reported on December 15, 2010. In 
the second survey, IgG seroprevalence 
within the 36 infected herds was 
51.7% (46/89). All IgM-positive 
horses and 23 (34%) of 68 clinically 
healthy horses had antibodies against 
WNV by blocking ELISA and SNT, 
indicating intense local transmission 
in 2010, which contrasts with previous 
observations (2).
On September 20, 2010, the fi rst 
case of WNV infection in a 60-year-
old man was confi rmed by detection 
of IgM by competitive ELISA and 
SNT. On October 6, 2010, a 77-year-
old case-patient was reported. Both 
patients, detected in the same area and 
period of the WNV outbreak (Figure), 
showed signs of encephalitis but 
were discharged after several days’ 
hospitalization. After the human cases 
were confi rmed, control measures, 
such as inclusion of West Nile 
fever  in the differential diagnosis of 
neurologic diseases and the control of 
blood samples from suspected cases 
and donors, were implemented.
WNV lineage 1 RNA was detected 
by real-time reverse transcription PCR 
in blood and cerebrospinal fl uid of 1 
of the 51 horses analyzed. Despite 
evidence that WNV persisted during 
the winter and reemerged during 
spring in the western Mediterranean, 
the Spanish strain (JF719069-
Spain/10/H-1b) and the strains isolated 
in Spain in 2007 and 2008 belong to 
clade 1a and clade 2, respectively (7). 
The closest relatives of the Spain/2010 
strain are the 2008 and 2009 Italian 
strains, with which it seems to share 
a common ancestor (7). Therefore, 
WNV may have circulated silently 
in the western Mediterranean region, 
establishing an endemic cycle after 
a single introduction. Alternatively, 
because Andalusia is located within 
the migratory fl yways for wild birds 
between Europe and Africa, the 
Spain/2010 strain might have been 
introduced putatively from Africa 
from the same source as the Italian 
strains. Further studies are needed to 
elucidate the origin of the Spain/2010 
strain.
Previous serologic surveys in 
migratory and resident wild birds 
from the affected area indicated 
WNV circulation during 2007 and 
2008 (3). Although high numbers of 
dead birds were reported in resident 
wild birds concurrently with the 
equine WNF outbreak, it appeared 
to be caused by another fl avivirus, 
Bagaza virus, not previously found 
in Europe (8). In 2010, Andalusia 
had the highest rainfall during spring 
and the hottest summer in the past 
decade (9), which provided optimal 
conditions for Culex spp. mosquitoes. 
An entomologic survey in the affected 
area in 2010 showed that the most 
abundant species was Cx. pipiens, 
with maximum abundance during 
June and September. The abundance 
of competent vectors and the high 
number of wild bird nesting areas in 
Andalusia provide ideal conditions 
for the maintenance and circulation 
of WNV. Therefore, the risk for 
reemergence of WNV in Spain should 
be considered high. To improve the 
early detection of WNV cases and 
prevent new outbreaks, a surveillance 
program of passive surveillance 
in humans, equids, and wild birds; 
serosurveillance in sentinel horses 
and wild birds; and entomologic 
surveillance was initiated after the 
2010 outbreak (10).
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Figure. Spatial distribution of West Nile virus–infected horse herds (gray dots), virus-
negative horse herds (white dots), and human cases (black dots) in Andalusia (southern 
Spain) at the end of 2010.
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Correction
Vol. 17, No. 11
In the article Lessons Learned during Public Health Response to Cholera Epidemic in Haiti and the 
Dominican Republic (J.W. Tappero, R.V. Tauxe), data in Figure 2 were published incorrectly. The corrected 
fi gure is provided here; the article has also been corrected online (wwwnc.cdc.gov/EID/article/17/11/11-0827_
article.htm). 
DOI: http://dx.doi.org/10.3201/eid1712.C11712
Figure 2. Reported cases of cholera by day, and 
14-day smoothed case-fatality rate (CFR) among 
hospitalized cases, by day, Haiti, October 22, 2010–
July 25, 2011. UN, United Nations; CDC, Centers 
for Disease Control and Prevention; PAHO, Pan 
American Health Organization; MSPP, Ministère de 
la Santé Publique et de la Population.
